https://stock.noler.com/us/stock/neubase-therapeutics-inc https://stock.noler.com/us/stock/neubase-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/neubase-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/neubase-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/neubase-therapeutics-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-cash-and-equivalents https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-contingent-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-current-assets-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-equipment https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-finite-lived-intangible-asset-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-intangibles https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquired-net https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisition-consideration-transferred https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisition-consideration-transferred-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisition-liabilities-arising-from-contingencies-amount-recognized https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/neubase-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/neubase-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/neubase-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/neubase-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/neubase-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/neubase-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/neubase-therapeutics-inc/amortization https://stock.noler.com/us/stock/neubase-therapeutics-inc/amortization-of-acquired-intangible-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/neubase-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/area-of-land https://stock.noler.com/us/stock/neubase-therapeutics-inc/assets-held-for-sale-not-part-of-disposal-group-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/neubase-therapeutics-inc/business-acquisition-equity-interest-issued-or-issuable-value-assigned https://stock.noler.com/us/stock/neubase-therapeutics-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/neubase-therapeutics-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/neubase-therapeutics-inc/buybacks-payments-for-repurchase-of-warrants https://stock.noler.com/us/stock/neubase-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/neubase-therapeutics-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/neubase-therapeutics-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/neubase-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-change https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/neubase-therapeutics-inc/cash-uninsured-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/neubase-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/neubase-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/neubase-therapeutics-inc/clinical-trials https://stock.noler.com/us/stock/neubase-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/neubase-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/neubase-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/neubase-therapeutics-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/neubase-therapeutics-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/convertible-debt-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/neubase-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/neubase-therapeutics-inc/current-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/neubase-therapeutics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/neubase-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-compensation-arrangement-with-individual-allocated-share-based-compensation-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-credits-and-other-liabilities-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-investments https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-warranty-reserves https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/neubase-therapeutics-inc/deferred-tax-liabilities-regulatory-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/defined-benefit-plan-special-termination-benefits https://stock.noler.com/us/stock/neubase-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/deposits-assets-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/depreciation https://stock.noler.com/us/stock/neubase-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/neubase-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/derivative-liabilities https://stock.noler.com/us/stock/neubase-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/neubase-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/neubase-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/neubase-therapeutics-inc/discontinued-operation-gain-loss-from-disposal-of-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/neubase-therapeutics-inc/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/neubase-therapeutics-inc/due-to-related-parties-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/neubase-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/neubase-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/eps https://stock.noler.com/us/stock/neubase-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/neubase-therapeutics-inc/equity-method-investments https://stock.noler.com/us/stock/neubase-therapeutics-inc/extinguishment-of-debt-gain-loss-income-tax https://stock.noler.com/us/stock/neubase-therapeutics-inc/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/neubase-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/neubase-therapeutics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/neubase-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-purchases-sales-issues-settlements https://stock.noler.com/us/stock/neubase-therapeutics-inc/fair-value-net-derivative-asset-liability-with-unobservable-inputs https://stock.noler.com/us/stock/neubase-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/neubase-therapeutics-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/neubase-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-license-agreements-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/neubase-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/neubase-therapeutics-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/neubase-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/neubase-therapeutics-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/neubase-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/neubase-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/neubase-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/goodwill https://stock.noler.com/us/stock/neubase-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/neubase-therapeutics-inc/grants-receivable-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/neubase-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/neubase-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/neubase-therapeutics-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-tax https://stock.noler.com/us/stock/neubase-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-prepaid-insurance https://stock.noler.com/us/stock/neubase-therapeutics-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/neubase-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/neubase-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/neubase-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/neubase-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/neubase-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/interest-income-expense-net https://stock.noler.com/us/stock/neubase-therapeutics-inc/interest-income-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/neubase-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/neubase-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/neubase-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/neubase-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/neubase-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/neubase-therapeutics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/neubase-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/neubase-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/level-3-liability-change https://stock.noler.com/us/stock/neubase-therapeutics-inc/level-3-liability-issues https://stock.noler.com/us/stock/neubase-therapeutics-inc/level-3-liability-settlements https://stock.noler.com/us/stock/neubase-therapeutics-inc/liabilities-noncurrent https://stock.noler.com/us/stock/neubase-therapeutics-inc/liabilities-subject-to-compromise-early-contract-termination-fees https://stock.noler.com/us/stock/neubase-therapeutics-inc/long-term-investments https://stock.noler.com/us/stock/neubase-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/neubase-therapeutics-inc/marketable-securities-gain-loss https://stock.noler.com/us/stock/neubase-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/neubase-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/neubase-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/neubase-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/neubase-therapeutics-inc/net-income https://stock.noler.com/us/stock/neubase-therapeutics-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-shares-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/notes-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/notes-reduction https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-income https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-leases-future-minimum-payments-next-rolling-twelve-months https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/neubase-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-expenses https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-income https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-income-2 https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-operating-income https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/neubase-therapeutics-inc/paid-in-capital-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/neubase-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/neubase-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/patents-active https://stock.noler.com/us/stock/neubase-therapeutics-inc/patents-pending https://stock.noler.com/us/stock/neubase-therapeutics-inc/patents-rejected https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-to-acquire-businesses-and-interest-in-affiliates https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-to-acquire-interest-in-joint-venture https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/neubase-therapeutics-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/neubase-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/neubase-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/neubase-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/neubase-therapeutics-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/neubase-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/neubase-therapeutics-inc/prepaid-rent https://stock.noler.com/us/stock/neubase-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-sale-of-other-productive-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/neubase-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/neubase-therapeutics-inc/professional-fees https://stock.noler.com/us/stock/neubase-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/neubase-therapeutics-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/neubase-therapeutics-inc/public-float https://stock.noler.com/us/stock/neubase-therapeutics-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/neubase-therapeutics-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/neubase-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/neubase-therapeutics-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/neubase-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/neubase-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/neubase-therapeutics-inc/restructuring-costs https://stock.noler.com/us/stock/neubase-therapeutics-inc/restructuring-costs-and-asset-impairment-charges https://stock.noler.com/us/stock/neubase-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/neubase-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/royalty-income-nonoperating https://stock.noler.com/us/stock/neubase-therapeutics-inc/salaries-and-wages https://stock.noler.com/us/stock/neubase-therapeutics-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/neubase-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-10-qt https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-15-12g https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-425 https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-certnas https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-s-4 https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/neubase-therapeutics-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/neubase-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/neubase-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/neubase-therapeutics-inc/security-deposit-liability https://stock.noler.com/us/stock/neubase-therapeutics-inc/share-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued-for-stock-awards https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued-shares-issued-for-noncash-consideration https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued-shares-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/shares-issued-shares-share-based-compensation-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/short-term-lease-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-non-option-equity-instruments-expirations https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-rsu-aggregate-intrinsic-value-outstanding https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-rsu-nonvested-intrinsic-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-shares-change https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-option-plan-expense https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-redeemed-or-called-shares https://stock.noler.com/us/stock/neubase-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/neubase-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/neubase-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/neubase-therapeutics-inc/total-assets https://stock.noler.com/us/stock/neubase-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/neubase-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/neubase-therapeutics-inc/transfer-of-investments https://stock.noler.com/us/stock/neubase-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/neubase-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/neubase-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/neubase-therapeutics-inc/value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/neubase-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/neubase-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/neubase-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted